Carolyn Rebeiro from Mining.com.au sits down with ABx Group Limited (ASX:ABX) Managing Director and CEO Dr Mark Cooksey and Corporate Connect Senior Equities Analyst Richard Close for an in-depth look at the company and its value proposition.
08 May 2023 - Empire Energy Group Limited (ASX:EEG) Managing Director Alex Underwood discusses NT Government approval for fracking in the Beetaloo Basin, exemptions for small producers, traditional owners, pipelines, government funding and the company's pilot project.
26 Nov 2024 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt reflects on a year marked by promising clinical trial results and a landmark partnership with Merck. He highlights progress in developing treatments for autoimmune diseases and anticipates milestones for the year ahead.
10 Jul 2024 - Santana Minerals Limited (ASX:SMI) CEO Damian Spring provides an update on the company's progress, discussing an increase in indicated resource at the RAS deposit, expected completion of the prefeasibility study, stakeholder engagement, and the possible impact of the Fast-Track Approvals Bill.
10 May 2024 - Empire Energy Group's journey toward Beetaloo Basin production and its strategic moves, including asset sales and capital raises, shaping Australia's gas sector landscape.
06 Nov 2019 - State Gas Limited (ASX:GAS) Executive Chairman, Richard Cottee provides an update on the company's key Reid’s Dome PL 231 gas project, drill program and timeline to production.
20 Aug 2021 - TALi Digital Limited (ASX:TD1) Managing Director Glenn Smith introduces the company’s software for the assessment and treatment of childhood attention difficulties and discusses the company's recent agreement with US company Akili.
26 Feb 2020 - Renergen Limited (ASX:RLT) Managing Director and CEO, Stefano Marani provides an update on recent drilling results at the company's Virginia Gas Project in South Africa, what’s planned for this year and the potential to bring forward a second production well.
16 Jun 2020 - Zelira Therapeutics Limited (ASX:ZLD) Managing Director Ex USA, Dr Richard Hopkins talks about the company's pipeline of products in clinical development targeting insomnia, chronic pain and autism, its model for rapid commercialisation, its go-to-market strategy and first revenues from US licensing partners.